SEC Form 13F
| Report period | 2025-09-30 |
|---|---|
| Publicly available | 2025-11-11 |
| Reported value | $55,636,803 |
| Positions | 4 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| TOURMALINE BIO INC | Unresolved | COM | $35,475,081 | 741,691 |
| KORRO BIO INC | KRRO | COM | $17,627,591 | 368,085 |
| JASPER THERAPEUTICS INC | JSPR | COM NEW | $2,210,934 | 928,964 |
| KEZAR LIFE SCIENCES INC | KZR | COM NEW | $323,197 | 82,871 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.